Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lip and oral cavity cancer
Stage/Subtype:  stage II lip and oral cavity cancer
Trial Type:  Treatment
Results 1-15 of 15 for your search:
Start Over
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 603EUSA03, NCI-2010-01741, NCT00901732
Vitamin D - Celecoxib Therapy
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 85
Trial IDs: CLIN-003-09S, NCI-2015-00330, NCT00953849
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Docetaxel, Cisplatin, and Cetuximab in Treating Patients With Metastatic or Relapsed Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Tadalafil in Treating Patients With Head and Neck Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: J1247, NCI-2012-02047, CIR00001158, NA_00073880, NCT01697800
Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 246513, NCI-2014-00756, NCT02119728
Azacitidine in Measuring Tumor Response in Patients with HPV Positive or Negative Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1404013771, NCI-2015-01437, 200 FR. 4 (2012-1), NCT02178072
Surgery with or without Stereotactic Body Radiotherapy in Treating Patients with Previously-Irradiated Head and Neck Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-151, NCI-2015-01424, NCT02516969
Biomarker Response to Cetuximab and VTX-2337 in Treating Patients with Stage II-IVA Head and Neck Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-002, NCI-2014-01430, UPCI #14-002, VRXP-A106, NCT02124850
Vaccine Therapy in Treating Patients with Stage I-IVA Head and Neck Squamous Cell Carcinoma That Have Undergone Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-160, NCI-2014-02500, 13-160, NCT02211027
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: OSU-07061, NCI-2011-03122, 2007C0090, NCT01473784
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Ganetespib before Surgery in Treating Patients with Stage I-IVA Squamous Cell Carcinoma of the Head and Neck That Can Be Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 to 79
Trial IDs: WINSHIP2572-13, NCI-2014-02605, NCT02334319
Transoral Robotic Surgery in Treating Patients With Oropharyngeal, Hypopharyngeal, and Oral Cavity Cancer
Phase: No phase specified
Type: Treatment
Age: 20 and over
Trial IDs: HNO 0601, NCI-2011-03028, NCT00473564
Start Over